Peoples Bancorp Inc/OH (PEBO)

NASDAQFinancialsBanks - RegionalSnapshot 2026-10-23

$38.20+0.03%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge Peoples Bancorp Inc/OH’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

+7.5%

+10% or more+5%0%−5%−10% or less

3.89 → 4.18 EPS · FY ending Dec 31, 2027 · 6 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 24, 2026 to Oct 24, 2026: (new ÷ prior − 1). Contributor count changed from 6 to 6; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Measure / period	Management expectations	Analyst expectations
Quarter ending 2026-12-30
Revenue	—	129.2M
EPS	—	0.931
Quarter ending 2027-03-31
Revenue	—	131.22M
EPS	—	0.881
Annual ending 2026-12-31
Revenue	—	492.15M
EPS	—	3.756
Annual ending 2027-12-31
Revenue	—	767.2M
EPS	—	4.183

Management figures unavailable.

What the Thesis Depends On

4 published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Successful integration of Citizens National Corporation acquisition	A primary condition in Peoples Bancorp Inc/OH's published investment case. The stated target is Acquisition completed and integrated by end of 2026.	Intact	Acquisition fails or integration causes material earnings disruption	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Maintain or increase quarterly dividend to at least $0.42 per share	It pays a steady dividend, recently raised to $0.42 per share.	Intact	dividend per share falls below $0.42	Dividend per share: $0.42 per share FY2026-Q2; GAAP. Published target: >= $0.42 per share quarterly. The target does not explicitly identify fiscal versus calendar quarters. Source published Jul 30, 20260.42 USD/share · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: fca26bd5-42e1-45be-9467-4aa3ebd8a00d. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
EPS at least $3.42 in fiscal 2026	A primary condition in Peoples Bancorp Inc/OH's published investment case. The stated target is >= $3.42 per share.	Intact	EPS falls below $3.42 in FY26	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Loan growth of 3-5% in fiscal 2026	A primary condition in Peoples Bancorp Inc/OH's published investment case. The stated target is 3-5% growth.	Broken	loan growth falls below 3% in FY26	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS$4.18

$3.85 → $4.18 · observed estimates

FY2027 revenueUnavailable

$0.53B → Unavailable · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$3.85	$532,133,330	7 / 6
2026-07-25	$3.88	$533,316,670	7 / 6
2026-07-26	$3.88	$533,316,670	7 / 6
2026-07-27	$3.88	$533,316,670	7 / 6
2026-07-28	$3.88	Unavailable	6 / 4
2026-07-29	$3.85	$532,133,330	7 / 6
2026-07-30	$3.88	$533,316,670	7 / 6
2026-07-31	$3.88	Unavailable	6 / 4
2026-08-01	$3.88	Unavailable	6 / 4
2026-08-02	$3.88	Unavailable	6 / 4
2026-08-03	$3.88	Unavailable	6 / 4
2026-08-04	$3.88	$533,316,670	7 / 6
2026-08-05	$3.88	$533,316,670	7 / 6
2026-08-06	$3.88	$533,316,670	7 / 6
2026-08-07	$3.88	Unavailable	6 / 4
2026-08-08	$3.88	$533,316,670	7 / 6
2026-08-09	$3.88	$533,316,670	7 / 6
2026-08-10	$3.88	Unavailable	6 / 4
2026-08-12	$3.88	$533,316,670	7 / 6
2026-08-13	$3.88	$533,316,670	7 / 6
2026-08-14	$3.88	Unavailable	6 / 4
2026-08-15	$3.88	Unavailable	6 / 4
2026-08-16	$3.88	Unavailable	6 / 4
2026-08-17	$3.88	Unavailable	6 / 4
2026-08-18	$3.88	Unavailable	6 / 4
2026-08-19	$3.88	Unavailable	6 / 4
2026-08-20	$3.88	Unavailable	6 / 4
2026-08-21	$3.88	Unavailable	6 / 4
2026-08-22	$3.88	Unavailable	6 / 4
2026-08-23	$3.88	Unavailable	6 / 4
2026-08-24	$3.88	Unavailable	6 / 4
2026-08-25	$3.88	Unavailable	6 / 4
2026-08-26	$3.88	Unavailable	6 / 4
2026-08-27	$3.88	Unavailable	6 / 4
2026-08-28	$3.88	Unavailable	6 / 4
2026-08-29	$3.88	Unavailable	6 / 4
2026-08-30	$3.88	Unavailable	6 / 4
2026-08-31	$3.88	Unavailable	6 / 4
2026-09-01	$3.88	Unavailable	6 / 4
2026-09-02	$3.88	Unavailable	6 / 4
2026-09-03	$3.88	Unavailable	6 / 4
2026-09-04	$3.88	Unavailable	6 / 4
2026-09-05	$3.88	Unavailable	6 / 4
2026-09-06	$3.88	Unavailable	6 / 4
2026-09-07	$3.88	Unavailable	6 / 4
2026-09-08	$3.88	Unavailable	6 / 4
2026-09-09	$3.88	Unavailable	6 / 4
2026-09-10	$3.88	Unavailable	6 / 4
2026-09-11	$3.88	Unavailable	6 / 4
2026-09-12	$3.88	Unavailable	6 / 4
2026-09-13	$3.88	Unavailable	6 / 4
2026-09-14	$3.88	Unavailable	6 / 4
2026-09-15	$3.88	Unavailable	6 / 4
2026-09-16	$3.88	Unavailable	6 / 4
2026-09-17	$3.88	Unavailable	6 / 4
2026-09-18	$3.88	Unavailable	6 / 4
2026-09-19	$3.88	Unavailable	6 / 4
2026-09-20	$3.88	Unavailable	6 / 4
2026-09-21	$3.88	Unavailable	6 / 4
2026-09-22	$3.88	Unavailable	6 / 4
2026-09-23	$3.89	Unavailable	6 / 4
2026-09-24	$3.89	Unavailable	6 / 4
2026-09-25	$3.89	Unavailable	6 / 4
2026-09-26	$3.89	$533,799,999	6 / 5
2026-09-27	$3.89	$533,799,999	6 / 5
2026-09-28	$3.89	$533,799,999	6 / 5
2026-09-29	$3.89	$533,799,999	6 / 5
2026-09-30	$3.89	$533,799,999	6 / 5
2026-10-01	$3.98	Unavailable	6 / 4
2026-10-02	Unavailable	Unavailable	4 / 3
2026-10-03	Unavailable	Unavailable	4 / 3
2026-10-04	Unavailable	Unavailable	3 / 2
2026-10-05	Unavailable	Unavailable	3 / 3
2026-10-06	Unavailable	Unavailable	3 / 3
2026-10-07	Unavailable	Unavailable	4 / 3
2026-10-08	Unavailable	Unavailable	4 / 3
2026-10-09	Unavailable	Unavailable	4 / 3
2026-10-10	Unavailable	Unavailable	4 / 3
2026-10-11	Unavailable	Unavailable	4 / 3
2026-10-12	Unavailable	Unavailable	4 / 3
2026-10-13	Unavailable	Unavailable	4 / 3
2026-10-14	Unavailable	Unavailable	4 / 3
2026-10-15	Unavailable	Unavailable	4 / 3
2026-10-16	Unavailable	Unavailable	4 / 3
2026-10-17	Unavailable	Unavailable	4 / 3
2026-10-18	$4.19	Unavailable	5 / 4
2026-10-19	$4.19	Unavailable	5 / 4
2026-10-20	$4.19	Unavailable	5 / 4
2026-10-21	$4.14	Unavailable	5 / 4
2026-10-22	$4.18	Unavailable	5 / 4
2026-10-23	$4.18	Unavailable	5 / 4
2026-10-24	$4.18	Unavailable	6 / 4

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	2	5
2026-06-01	2	5
2026-07-01	2	5
2026-08-01	2	5
2026-09-01	2	5
2026-10-01	2	5

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 2 Buy / Strong Buy · 5 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades2 maintains

Recent actions · Sep 25–Oct 24 · 2 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

Piper SandlerOct 22 · prior Oct 5

$42.00 → $48.00+14.3%

D.A. DavidsonOct 1 · prior Jul 22

$44.00 → $42.00-4.5%

$0$26.40$52.80

1 raises · 1 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Successful integration of Citizens National Corporation acquisitionDirect metric needs a verified mapping
Maintain or increase quarterly dividend to at least $0.42 per shareDividend per share: $0.42 per share
EPS at least $3.42 in fiscal 2026Direct metric needs a verified mapping
Loan growth of 3-5% in fiscal 2026Published status: Broken

Next proof point

Next earnings date unavailable

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

0.8%Typical daily move · historical

Downside history

-15.3%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Peoples Bancorp Inc/OH outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

This is a regional banking and acquisition-led growth story, rather than a proven durable compounder. The long-term thesis is in a watch state: company momentum improved, but recent financial performance remains below its industry cohort.

What's priced into Peoples Bancorp Inc/OH

The valuation evidence points to PEBO being cheap versus peers, with the market’s expectations below the model’s view. Pricing is tagged as justified, and fragility is low, so the snapshot does not indicate unusually stretched expectations.

What the fundamentals likely do

Near term, the October 20 earnings beat and stronger company momentum are positive, but supplied results show net income eased from the first to second quarter, and merger benefits are not isolated. Integration remains in progress, acquisition expenses were reported in the third-quarter release, and the financial-sector backdrop is a headwind; miss risk is rated quiet.

What Peoples Bancorp Inc/OH hinges on

Over the next few quarters, the thesis hinges on whether PEBO completes and integrates the Citizens and Capital mergers and turns its acquisition strategy into financial delivery. A guidance cut or Fed rate cuts would be unfavorable, while continued earnings strength from sector bellwethers could support sector momentum.